26 May 2025
Cancers | Editor’s Choice Articles Published in 2024 and Special Issues in the “Cancer Drug Development” Section


We are delighted to share some of the most viewed papers in the “Cancer Drug Development” Section that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, a few Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that may be of interest to you.

The list of relevant papers can be seen below:

“Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs”
by Virginia Metrangolo and Lars H. Engelholm
Cancers 2024, 16(2), 447; https://doi.org/10.3390/cancers16020447
Available online: https://www.mdpi.com/2072-6694/16/2/447

“The Anticancer Application of Delivery Systems for Honokiol and Magnolol”
by Katarzyna Dominiak, Aleksandra Gostyńska, Michał Szulc and Maciej Stawny
Cancers 2024, 16(12), 2257; https://doi.org/10.3390/cancers16122257
Available online: https://www.mdpi.com/2072-6694/16/12/2257

“Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development”
by Whi-An Kwon, Seo-Yeon Lee, Tae Yoong Jeong, Hyeon Hoe Kim and Min-Kyung Lee
Cancers 2024, 16(13), 2420; https://doi.org/10.3390/cancers16132420
Available online: https://www.mdpi.com/2072-6694/16/13/2420

“The Microbiome Modulates the Immune System to Influence Cancer Therapy”
by Ruchi Roy and Sunil Kumar Singh
Cancers 2024, 16(4), 779; https://doi.org/10.3390/cancers16040779
Available online: https://www.mdpi.com/2072-6694/16/4/779

“Oligometastasis of Gastric Cancer: A Review”
by Itaru Yasufuku, Hiroshi Tsuchiya, Seito Fujibayashi, Naoki Okumura, Yuki Sengoku, Masahiro Fukada, Ryuichi Asai, Yuta Sato, Jesse Yu Tajima, Shigeru Kiyama et al.
Cancers 2024, 16(3), 673; https://doi.org/10.3390/cancers16030673
Available online: https://www.mdpi.com/2072-6694/16/3/673

Special Issues:

Radiopharmaceuticals for Cancers
Guest Editors: Dr. Joseph Lau and Dr. Hwan Lee
Submission deadline: 30 October 2025
Advances in Drug Repurposing to Overcome Cancers
Guest Editor: Dr. Rafal Bartoszewski
Submission deadline: 30 August 2025
Research on New Drugs and Drug Targets in Melanoma
Guest Editors: Dr. Paula Wróblewska Łuczka and Dr. Nicolas Dumaz
Submission deadline: 20 August 2025
Development of Biomarkers and Antineoplastic Drugs in Solid Tumors
Guest Editors: Dr. Rosa Falcone, Dr. Sofia Verkhovskaia and Dr. Michela Roberto
Submission deadline: 31 July 2025

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Back to TopTop